English
- English
- 中文
-
PanMediso | News Center
-
News Center
-
Pamedic Moment｜An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
August 14, 2025 — Beijing, China. Pamedic, An Asian Company Conquers Ac-225 Core Technology, Tsinghua and Pamedic Solve Global Cancer Isotope Dilemma.
-
Pamedic Moment｜An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparati
-
Pamedic Moment｜Focusing on Nuclear Medicine, The Hong Kong Polytechnic University and Pamedic Holdings Enter into a Partnership
On May 16th, the 4th Asia Summit on Global Health was held at the Hong Kong Conv
-
Pamedic Moment | Project of Medical Isotopes Preparation via Accelerator Kicks Off
Resource: www.xinhuanet.com On 28th March, the signing ceremony for the R&D Proj
Nuclear Drugs Tsinghua University Medical Isotopes Preparation
-
Pamedic Moment | Exploring Actinium in Radiopharmaceuticals[225Ac]
Radiopharmaceuticals, the new star in medical field nowadays, are gradually ejec
isotopic nuclear medicine radiopharmaceutical
-
Pamedic Moment | Jonathan Sackier in Interview, “Dedicated to Cancer Treatment for Chinese”
Jonathan Sackier, the Chief Medical Officer of Pamedic Holdings Limited（hereinafter “PMHL”）:We will deepen our collaboration with Shenzhen and the entire China, dedicated to providing innovative treatment solutions for 8 million Chinese and even global cancer patients.
![Pamedic Moment | Exploring Actinium in Radiopharmaceuticals[225Ac]](https://gcdn.meidianbang.cn/comdata/81850/202402/20240204111526bd6d9e.jpg "Pamedic Moment | Exploring Actinium in Radiopharmaceuticals[225Ac]")
新闻中心
-
Pamedic Moment｜An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
August 14, 2025 — Beijing, China. Pamedic, An Asian Company Conquers Ac-225 Core Technology, Tsinghua and Pamedic Solve Global Cancer Isotope Dilemma.
-
Pamedic Moment｜An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparati
-
Pamedic Moment｜Focusing on Nuclear Medicine, The Hong Kong Polytechnic University and Pamedic Holdings Enter into a Partnership
On May 16th, the 4th Asia Summit on Global Health was held at the Hong Kong Conv
-
Pamedic Moment | Project of Medical Isotopes Preparation via Accelerator Kicks Off
Resource: www.xinhuanet.com On 28th March, the signing ceremony for the R&D Proj
Nuclear Drugs Tsinghua University Medical Isotopes Preparation
-
Pamedic Moment | Exploring Actinium in Radiopharmaceuticals[225Ac]
Radiopharmaceuticals, the new star in medical field nowadays, are gradually ejec
isotopic nuclear medicine radiopharmaceutical
-
Pamedic Moment | Jonathan Sackier in Interview, “Dedicated to Cancer Treatment for Chinese”
Jonathan Sackier, the Chief Medical Officer of Pamedic Holdings Limited（hereinafter “PMHL”）:We will deepen our collaboration with Shenzhen and the entire China, dedicated to providing innovative treatment solutions for 8 million Chinese and even global cancer patients.
Email: pchl@pamedicholdings.com
Address: Room 406, Building C, Hetao Innovation Center No. 1 Honghua
Road, Fubao Subdistrict Futian District, Shenzhen, China
Copyright@2025 PanMediso
